Despite similar weight loss and resultant BMIs across the groups at 3 to 6 months and despite dramatic improvements in insulin sensitivity, β-cell function in obese participants with NFG and IFG improved to levels similar to those in normal weight controls, whereas β-cell function tended to remain lower in obese participants with T2DM compared with normal weight participants. This evidence concerns the gene INS and type 2 diabetes mellitus.